It has been reported that SOX2 expression is associated with the promotion of tamoxifen resistance in breast cancer, and that ectopic expression of SOX2 contributes to tamoxifen resistance in the MCF-7 breast cancer cell line [45]. Here, SOX2 is linked to breast carcinoma.